S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SABS SAB Biotherapeutics Inc

1.435

0.045 (3.24%)

Apr 17 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

SAB Biotherapeutics (NASDAQ:SABS)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more SAB Biotherapeutics Charts.

SAB Biotherapeutics (NASDAQ:SABS)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more SAB Biotherapeutics Charts.

SAB Biotherapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 13 August 2024 (8 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 12 August 2024 (8 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (8 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 31 July 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 31 July 2024 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 July 2024 (9 months ago) • Edgar (US Regulatory)

SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
Monday 20 May 2024 (11 months ago) • GlobeNewswire Inc.

SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
Monday 6 May 2024 (11 months ago) • GlobeNewswire Inc.

More SAB Biotherapeutics Inc News Articles

Exchange Traded

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions